CMIC Holdings Co Ltd
TSE:2309
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2 621
999 999.9999
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
CMIC Holdings Co Ltd
Accrued Liabilities
CMIC Holdings Co Ltd
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
CMIC Holdings Co Ltd
TSE:2309
|
Accrued Liabilities
ÂĄ1.7B
|
CAGR 3-Years
38%
|
CAGR 5-Years
24%
|
CAGR 10-Years
13%
|
||
C
|
Chiome Bioscience Inc
TSE:4583
|
Accrued Liabilities
ÂĄ18.1m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-10%
|
|
Precision System Science Co Ltd
TSE:7707
|
Accrued Liabilities
ÂĄ44.1m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
44%
|
CAGR 10-Years
20%
|
||
Medinet Co Ltd
TSE:2370
|
Accrued Liabilities
ÂĄ32.6m
|
CAGR 3-Years
11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-2%
|
||
CellSource Co Ltd
TSE:4880
|
Accrued Liabilities
ÂĄ132.7m
|
CAGR 3-Years
18%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
||
WDB coco Co Ltd
TSE:7079
|
Accrued Liabilities
ÂĄ255.7m
|
CAGR 3-Years
11%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
CMIC Holdings Co Ltd
Glance View
CMIC Holdings Co., Ltd. engages in the provision of support services for pharmaceutical development, manufacturing, and sales. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 5,569 full-time employees. The company went IPO on 2004-06-18. The Contract Research Organization (CRO) segment offers monitoring, data management, pharmaceutical consulting and nonclinical services. The Contract Manufacturing Organization (CMO) segment is engaged in the entrusted manufacture of drugs for pharmaceutical companies. The Contract Sales Organization (CSO) segment is engaged in the operation and marketing support for medicinal products. The Health Care segment conducts site support institute (SMO) business, and provides health care information services. The Intellectual Property Development (IPD) segment develops and sells diagnostic products and orphan drugs.
See Also
What is CMIC Holdings Co Ltd's Accrued Liabilities?
Accrued Liabilities
1.7B
JPY
Based on the financial report for Dec 31, 2023, CMIC Holdings Co Ltd's Accrued Liabilities amounts to 1.7B JPY.
What is CMIC Holdings Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
13%
Over the last year, the Accrued Liabilities growth was -24%. The average annual Accrued Liabilities growth rates for CMIC Holdings Co Ltd have been 38% over the past three years , 24% over the past five years , and 13% over the past ten years .